marketcaparena

AVBP

ArriVent BioPharma, Inc.

Company overview

Market capitalization
$1.44B
Employees
77
Latest publication
2026-09-29
About ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company's lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002, ARR-421, and ARR-173 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
Research Development37,617,000USD32,175,000USD32,167,000USD27,720,000USD61,289,000USD20,163,000USD20,088,000USD21,778,000USD
Selling General Administrative8,494,000USD6,648,000USD6,149,000USD5,903,000USD5,483,000USD3,542,000USD4,144,000USD3,919,000USD
Total Operating Expenses46,111,000USD38,823,000USD38,316,000USD33,623,000USD66,772,000USD23,705,000USD24,232,000USD25,697,000USD
Operating Income-46,111,000USD-38,823,000USD-38,316,000USD-33,623,000USD-66,772,000USD-23,705,000USD-24,232,000USD-25,697,000USD
Interest Income2,791,000USD3,279,000USD3,338,000USD2,224,000USD2,385,000USD3,072,000USD3,668,000USD3,823,000USD
Net Interest Income2,791,000USD3,279,000USD3,338,000USD2,224,000USD2,385,000USD3,072,000USD3,668,000USD3,823,000USD
Income Before Tax-43,320,000USD-35,544,000USD-34,978,000USD-31,399,000USD-64,387,000USD-20,633,000USD-20,564,000USD-21,874,000USD
Net Income-43,320,000USD-35,544,000USD-34,978,000USD-31,399,000USD-64,387,000USD-20,633,000USD-20,564,000USD-21,874,000USD
Net Income From Continuing Ops-43,320,000USD-35,544,000USD-34,978,000USD-31,399,000USD-64,387,000USD-20,633,000USD-20,564,000USD-21,874,000USD
Ebitda-46,111,000USD-38,823,000USD-34,978,000USD-31,399,000USD-66,772,000USD-23,705,000USD-24,232,000USD-25,697,000USD
Total Other Income Expense Net2,791,000USD3,279,000USD3,338,000USD2,224,000USD2,385,000USD3,072,000USD3,668,000USD3,823,000USD
Ebit———-33,623,000USD-66,772,000USD-23,705,000USD-24,232,000USD-25,697,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
Total Revenue0USD0USD0USD0USD—
Research Development153,351,000USD79,004,000USD64,884,000USD30,433,000USD6,434,000USD
Selling General Administrative24,183,000USD15,304,000USD9,706,000USD6,473,000USD3,016,000USD
Total Operating Expenses177,534,000USD94,308,000USD74,590,000USD36,906,000USD8,696,000USD
Operating Income-177,534,000USD-94,308,000USD-74,590,000USD-36,906,000USD-8,696,000USD
Interest Income11,226,000USD13,820,000USD5,257,000USD0USD—
Net Interest Income11,226,000USD13,820,000USD5,257,000USD0USD—
Income Before Tax-166,308,000USD-80,488,000USD-69,333,000USD-36,906,000USD-51,606,000USD
Net Income-166,308,000USD-80,488,000USD-69,333,000USD-36,906,000USD-51,606,000USD
Net Income From Continuing Ops-166,308,000USD-80,488,000USD-69,333,000USD-36,906,000USD—
Ebitda-177,534,000USD-80,488,000USD-74,590,000USD-36,906,000USD-51,606,000USD
Total Other Income Expense Net11,226,000USD13,820,000USD5,257,000USD—-42,910,000USD
Income Tax Expense—-80,488,000USD—-36,906,000USD-11,594,664USD
Ebit—-94,308,000USD-74,590,000USD-73,812,000USD-63,200,664USD
Depreciation And Amortization———36,906,000USD11,594,664USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
Total Assets394,718,000USD333,169,000USD326,555,000USD269,506,000USD215,495,000USD274,942,000USD292,711,000USD308,855,000USD
Cash And Equivalents154,682,000USD———————
Cash And Short Term Investments373,119,000USD312,821,000USD300,266,000USD235,687,000USD176,077,000USD218,863,000USD282,855,000USD298,669,000USD
Short Term Investments218,437,000USD267,281,000USD187,594,000USD122,922,000USD126,212,000USD144,570,000USD——
Total Current Assets394,173,000USD332,897,000USD321,218,000USD250,149,000USD185,785,000USD226,979,000USD292,398,000USD308,511,000USD
Other Current Assets21,054,000USD20,076,000USD20,447,000USD13,957,000USD9,203,000USD7,616,000USD9,043,000USD9,092,000USD
Other Non Current Assets134,000USD———————
Total Liabilities27,877,000USD———————
Total Current Liabilities27,844,000USD25,945,000USD21,558,000USD19,636,000USD12,953,000USD17,274,000USD15,162,000USD12,098,000USD
Other Current Liabilities25,309,000USD———————
Total Stockholder Equity366,841,000USD307,224,000USD304,997,000USD249,870,000USD202,542,000USD257,654,000USD277,493,000USD296,659,000USD
Total Equity Including Noncontrolling Interest366,841,000USD———————
Property Plant Equipment Net370,000USD13,000USD49,000USD85,000USD120,000USD154,000USD187,000USD219,000USD
Accounts Payable2,217,000USD5,934,000USD5,933,000USD4,060,000USD4,364,000USD3,782,000USD4,646,000USD3,812,000USD
Short Term Debt318,000USD14,000USD56,000USD98,000USD138,000USD162,000USD297,000USD152,000USD
Common Stock5,000USD4,000USD4,000USD4,000USD4,000USD3,000USD3,000USD3,000USD
Retained Earnings-497,854,000USD-404,641,000USD-369,097,000USD-334,119,000USD-302,720,000USD-238,333,000USD-217,700,000USD-197,136,000USD
Accumulated Other Comprehensive Income-267,000USD14,000USD206,000USD-18,000USD-17,000USD-211,000USD—0USD
Total Liab—25,945,000USD21,558,000USD19,636,000USD12,953,000USD17,288,000USD15,218,000USD12,196,000USD
Other Current Liab—19,997,000USD15,569,000USD15,478,000USD8,451,000USD13,330,000USD10,219,000USD8,134,000USD
Capital Stock—4,000USD4,000USD4,000USD4,000USD3,000USD0USD3,000USD
Cash—45,540,000USD112,672,000USD112,765,000USD49,865,000USD74,293,000USD282,855,000USD298,669,000USD
Net Debt—-45,526,000USD-112,616,000USD-112,667,000USD-49,727,000USD-74,117,000USD-282,502,000USD-298,419,000USD
Short Long Term Debt Total—14,000USD56,000USD98,000USD138,000USD176,000USD353,000USD250,000USD
Long Term Investments—0USD5,108,000USD18,793,000USD29,414,000USD47,683,000USD——
Property Plant Equipment Gross—13,000USD49,000USD85,000USD120,000USD154,000USD291,000USD219,000USD
Common Stock Shares Outstanding—38,462,600shares41,912,905shares35,006,114shares33,899,000shares33,581,810shares33,581,810shares33,509,090shares
Non Current Assets Total—272,000USD5,337,000USD19,357,000USD29,710,000USD47,963,000USD313,000USD344,000USD
Non Current Liabilities Total—0USD0USD0USD0USD14,000USD56,000USD98,000USD
Non Currrent Assets Other—259,000USD180,000USD479,000USD176,000USD126,000USD126,000USD125,000USD
Net Working Capital—306,952,000USD299,660,000USD230,513,000USD172,832,000USD209,705,000USD148,344,000USD296,413,000USD
Unclassified Equity—711,843,000USD673,880,000USD583,999,000USD505,271,000USD496,192,000USD495,190,000USD493,789,000USD
Net Receivables——505,000USD505,000USD505,000USD500,000USD500,000USD750,000USD
Other Assets———————1USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
Total Assets333,169,000USD274,942,000USD163,098,000USD182,833,000USD43,039,000USD
Other Current Assets20,076,000USD7,616,000USD9,579,000USD19,250,000USD5,672,000USD
Total Liab25,945,000USD17,288,000USD11,801,000USD8,371,000USD1,818,000USD
Total Stockholder Equity307,224,000USD257,654,000USD151,297,000USD174,462,000USD41,221,000USD
Other Current Liab19,997,000USD13,330,000USD6,952,000USD5,138,000USD1,525,000USD
Common Stock4,000USD3,000USD—4,000USD4,000USD
Capital Stock4,000USD3,000USD0USD0USD89,865,000USD
Retained Earnings-404,641,000USD-238,333,000USD-157,845,000USD-88,512,000USD-51,606,000USD
Cash45,540,000USD74,293,000USD150,389,000USD163,372,000USD37,280,000USD
Cash And Short Term Investments312,821,000USD218,863,000USD150,389,000USD163,372,000USD37,280,000USD
Total Current Assets332,897,000USD226,979,000USD159,968,000USD182,622,000USD42,952,000USD
Total Current Liabilities25,945,000USD17,274,000USD11,624,000USD8,360,000USD1,818,000USD
Net Debt-45,526,000USD-74,117,000USD-150,072,000USD-163,233,000USD-37,280,000USD
Short Term Debt14,000USD162,000USD140,000USD128,000USD—
Short Long Term Debt Total14,000USD176,000USD317,000USD139,000USD—
Long Term Investments0USD47,683,000USD0USD——
Short Term Investments267,281,000USD144,570,000USD0USD——
Accounts Payable5,934,000USD3,782,000USD4,532,000USD3,094,000USD293,000USD
Property Plant Equipment Net13,000USD154,000USD291,000USD139,000USD0USD
Property Plant Equipment Gross13,000USD154,000USD291,000USD139,000USD0USD
Accumulated Other Comprehensive Income14,000USD-211,000USD—-4,000USD-2,000USD
Common Stock Shares Outstanding38,462,600shares31,469,328shares31,956,657shares33,493,750shares1,276,250shares
Non Current Assets Total272,000USD47,963,000USD3,130,000USD211,000USD87,000USD
Non Current Liabilities Total0USD14,000USD177,000USD11,000USD0USD
Non Currrent Assets Other259,000USD126,000USD2,839,000USD72,000USD87,000USD
Net Working Capital306,952,000USD209,705,000USD148,344,000USD174,262,000USD41,134,000USD
Unclassified Equity711,843,000USD496,192,000USD309,142,000USD262,974,000USD2,960,000USD
Net Receivables—500,000USD761,000USD500,000USD250,000USD
Inventory——-240,000USD——
Other Assets———1USD1USD
Current Deferred Revenue———-1USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
Net Income-43,320,000USD-35,544,000USD-34,978,000USD-31,399,000USD-64,387,000USD-20,633,000USD-20,564,000USD-21,874,000USD
Depreciation-559,000USD-3,026,000USD——————
Stock Based Compensation5,485,000USD3,222,000USD3,716,000USD3,311,000USD2,271,000USD952,000USD866,000USD765,000USD
Other Non Cash Items4,926,000USD————951,999USD835,000USD-347,000USD
Change In Working Capital-3,498,000USD4,690,000USD-4,536,000USD1,964,000USD-5,892,000USD3,529,000USD3,353,000USD2,022,000USD
Total Cash From Operating Activities-41,892,000USD-30,658,000USD-35,798,000USD-26,124,000USD-68,008,000USD-16,152,000USD-16,345,000USD-19,087,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-41,892,000USD-30,658,000USD-35,798,000USD-26,124,000USD-68,008,000USD-16,152,000USD-16,345,000USD-19,087,000USD
Investments3,582,000USD-71,199,000USD-50,760,000USD13,910,000USD36,821,000USD-192,465,000USD0USD0USD
Total Cashflows From Investing Activities3,582,000USD-71,199,000USD-50,760,000USD13,910,000USD36,821,000USD-192,465,000USD——
Total Cash From Financing Activities54,873,000USD34,725,000USD86,465,000USD75,114,000USD6,759,000USD55,000USD531,000USD363,000USD
Issuance Of Capital Stock54,724,000USD34,658,000USD86,116,000USD75,341,000USD6,516,000USD0USD0USD319,000USD
Change In Cash16,563,000USD-67,132,000USD-93,000USD62,900,000USD-24,428,000USD-208,562,000USD-15,814,000USD-18,724,000USD
Begin Period Cash Flow45,540,000USD112,672,000USD112,765,000USD49,865,000USD74,293,000USD282,855,000USD298,669,000USD317,393,000USD
End Period Cash Flow62,103,000USD45,540,000USD112,672,000USD112,765,000USD49,865,000USD74,293,000USD282,855,000USD298,669,000USD
Other Cashflows From Financing Activities54,873,000USD-70,000USD—-227,000USD243,000USD55,000USD531,000USD44,000USD
Unclassified Operating Cash Flow-4,926,000USD———————
Unclassified Financing Cash Flow-54,724,000USD———————
Other Cashflows From Investing Activities—————1,699,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
Net Income-166,308,000USD-80,488,000USD-69,333,000USD-36,906,000USD-51,606,000USD
Depreciation-3,026,000USD————
Stock Based Compensation12,520,000USD3,208,000USD895,000USD424,000USD66,667USD
Other Non Cash Items-3,026,000USD—1,379USD-2,376,000USD42,960,000USD
Change In Working Capital-3,774,000USD7,068,000USD12,596,000USD-7,149,000USD-3,941,000USD
Total Cash From Operating Activities-160,588,000USD-70,212,000USD-55,842,000USD-43,631,000USD-12,587,000USD
Capital Expenditures0USD0USD0USD0USD0USD
Free Cash Flow-160,588,000USD-70,212,000USD-55,842,000USD-43,631,000USD-12,587,000USD
Investments-71,228,000USD-192,465,000USD0USD0USD—
Total Cashflows From Investing Activities-71,228,000USD-192,465,000USD——-40,000,000USD
Total Cash From Financing Activities203,063,000USD186,581,000USD42,859,000USD169,723,000USD89,867,000USD
Issuance Of Capital Stock202,631,000USD185,950,000USD44,919,000USD169,708,000USD—
Change In Cash-28,753,000USD-76,096,000USD-12,983,000USD126,092,000USD37,280,000USD
Begin Period Cash Flow74,293,000USD150,389,000USD163,372,000USD37,280,000USD—
End Period Cash Flow45,540,000USD74,293,000USD150,389,000USD163,372,000USD37,280,000USD
Other Cashflows From Financing Activities-70,000USD631,000USD42,859,000USD169,721,000USD119,822,000USD
Unclassified Operating Cash Flow3,026,000USD——2,376,000USD—
Unclassified Financing Cash Flow——-44,919,000USD-169,706,000USD-29,955,000USD
Net Borrowings———0USD—
Other Cashflows From Investing Activities————-40,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.